Tower Research Capital LLC (TRC) - OMEGA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,553
-9.1%
4,908
+136.6%
0.00%
Q2 2023$11,614
+15594.6%
2,074
-82.9%
0.00%
-100.0%
Q1 2023$74
+221.7%
12,163
+207.8%
0.00%
+100.0%
Q4 2022$23
-100.0%
3,952
-55.9%
0.00%0.0%
Q3 2022$49,000
+157.9%
8,963
+72.0%
0.00%
Q2 2022$19,000
+90.0%
5,210
+211.4%
0.00%
Q1 2022$10,000
-80.8%
1,673
-63.7%
0.00%
-100.0%
Q4 2021$52,000
+642.9%
4,614
+1114.2%
0.00%
Q3 2021$7,0003800.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 25,902,269$293,473,0004.54%
CHI Advisors LLC 1,055,882$11,964,0003.97%
HARBOURVEST PARTNERS LLC 2,647,059$29,991,0003.83%
72 Investment Holdings, LLC 352,941$3,999,0003.55%
Monashee Investment Management LLC 441,176$4,999,0001.24%
Artal Group S.A. 2,273,530$25,759,0000.70%
SPHERA FUNDS MANAGEMENT LTD. 352,948$3,999,0000.44%
Octagon Capital Advisors LP 176,470$1,999,0000.39%
PLATINUM INVESTMENT MANAGEMENT LTD 414,513$4,696,0000.13%
Logos Global Management LP 88,235$999,0000.10%
View complete list of OMEGA THERAPEUTICS INC shareholders